Sanotize is recruiting for a COVID trial in the province of Quebec.   

Dr. Gilly Regev, PhD

Chief Executive Officer & Co-Founder

Experienced biotech executive with hands-on experience in launching pharmaceutical enterprises

  • Hands-on experience in drug development, intellectual property development and clinical trials.
  • Experience in early stage biotech fundraising and licensing deals.
  • 30 years of experience in research and development in biochemistry, analytic chemistry and microbiology
  • Spent the last 12 years in the field of nitric oxide, including tenure as the Chief Scientific Officer for Bovicor (animal health company)
  • PhD in Biochemistry from the Hebrew University of Jerusalem

Dr. Chris Miller, PhD, BA, RT

Chief Science Officer & Co-Founder

A pioneer in nitric oxide technology and therapeutic research (over 25 years)

  • Co-founder and CEO of Pulmonox Research and Development Corporation (1993) based on nitric oxide gas as a platform technology
  • 20 years of expertise in clinical trials
  • 20 years of experience in Intellectual Property, regulatory and management
  • Assistant Professor in the Faculty of Medicine, Respiratory Division, University of British Columbia
  • PhD in Experimental Medicine and degrees in Health Management and Respiratory Therapy
logged in